A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Sanofi stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 59,424 shares of SNY stock, worth $2.87 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
59,424
Previous 24,741 140.18%
Holding current value
$2.87 Million
Previous $1.2 Million 185.5%
% of portfolio
0.07%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$48.54 - $58.53 $1.68 Million - $2.03 Million
34,683 Added 140.18%
59,424 $3.43 Million
Q2 2024

Jul 23, 2024

BUY
$45.39 - $50.36 $679,896 - $754,342
14,979 Added 153.44%
24,741 $1.2 Million
Q1 2024

Apr 11, 2024

BUY
$45.75 - $52.48 $446,611 - $512,309
9,762 New
9,762 $474,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.